Artiva Biotherapeutics Inc. (ARTV)
NASDAQ · Healthcare
Artiva Biotherapeutics Inc. Total Liabilities 2023–2025
Artiva Biotherapeutics Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Artiva Biotherapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 21.0M, a 8.59% decrease year-over-year.
- Artiva Biotherapeutics Inc. total liabilities for 2025 were 21.0M, a 8.59% decrease from 2024.
- Artiva Biotherapeutics Inc. total liabilities for 2024 were 22.9M, a 54.77% decrease from 2023.
- Artiva Biotherapeutics Inc. total liabilities for 2023 were 50.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Artiva Biotherapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $21 |
| 2024 | $23 |
| 2023 | $51 |
| Artiva Biotherapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $21 |
| 2024-12-31 | $23 |
| 2023-12-31 | $51 |
Artiva Biotherapeutics Inc. Total Liabilities — FAQ
Artiva Biotherapeutics Inc. (ARTV) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARTV's total liabilities history?
The chart and table above show Artiva Biotherapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.